Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival.

MLA

Menu, Eline, et al. “Targeting the IGF-1R Using Picropodophyllin in the Therapeutical 5T2MM Mouse Model of Multiple Myeloma: Beneficial Effects on Tumor Growth, Angiogenesis, Bone Disease and Survival.” International Journal of Cancer, vol. 121, no. 8, Oct. 2007, pp. 1857–61. EBSCOhost, https://doi.org/10.1002/ijc.22845.

APA

Menu, E., Jernberg-Wiklund, H., De Raeve, H., De Leenheer, E., Coulton, L., Gallagher, O., Van Valckenborgh, E., Larsson, O., Axelson, M., Nilsson, K., Van Camp, B., Croucher, P., & Vanderkerken, K. (2007). Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival. International Journal of Cancer, 121(8), 1857–1861. https://doi.org/10.1002/ijc.22845

Chicago

Menu, Eline, Helena Jernberg-Wiklund, Hendrik De Raeve, Evy De Leenheer, Les Coulton, Orla Gallagher, Els Van Valckenborgh, et al. 2007. “Targeting the IGF-1R Using Picropodophyllin in the Therapeutical 5T2MM Mouse Model of Multiple Myeloma: Beneficial Effects on Tumor Growth, Angiogenesis, Bone Disease and Survival.” International Journal of Cancer 121 (8): 1857–61. doi:10.1002/ijc.22845.